Dow Down 0.47% Nasdaq Down 0.01%

ArQule Inc. (ARQL)

-NasdaqGM
1.29 Down 0.03(2.27%) 1:13PM EDT - Nasdaq Real Time Price
Prev Close:1.32
Open:1.32
Bid:1.29 x 4600
Ask:1.30 x 6400
1y Target Est:3.06
Beta:1.25
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:1.29 - 1.33
52wk Range:1.24 - 2.94
Volume:77,117
Avg Vol (3m):506,989
Market Cap:80.98M
P/E (ttm):N/A
EPS (ttm):-0.42
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ARQL

Comparison

Symbol% ChgMkt Cap
ARQLDown 2.27%80.98M
ARRYDown 1.27%514.11M
ASTX 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):7.27
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.46
Quarterly EPS Est (Sep-14) :-0.13
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):-0.56

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ArQule, Inc., a clinical-stage biotechnology company, researches and develops cancer therapeutics. Its lead product candidate tivantinib is an inhibitor of the c-Met receptor tyrosine kinase and its biological pathway, which is in Phase 3 clinical... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback